S70
Ltzitrs
In both cases, numerical aberrations of ihe X chromosomes as a cause for the uncommon fiuorescent PCR patrerns were excluded by rhe presence of a normal 46,XX karyorype.
These rwo patients show a similar deletion with an equivalent mosaicism race in blood, bur a distinct clinicaJ presenration. X inacrivation study on probanci 1 with typical Rert syndrome showed a random partem of inactivarion in rhe periphera! blood. Although the results have co be extrapo!ated from the peripheraJ blood cells, it would suggest that in the brain the majoriry of murated X chromosomes may remain active in the gir; with dassicai Ren syndrome. Our results illusrrate cJearly once again the difficulty in esrablishing a correlation berween genotype ar.d phenotype in RTT.
Recenrly, a boy with a mosaic mutation has been describedT To our knowledge, we show for the first time that somatic mosaicism for MECP2 mutation in girls is not infreąuent (iwo somatic murations on 102 puiarive RTT cases studiea) and may cause different phenorypes. These clinical and molecular hndings suggest that multiple forms of mosaicism (X inacriva-tion mosaicism and somatic mosaicism) may be presenr in a single paiienr with RTT. Mosaicism has been documented for chromosomai abnormaliries, mitochondnaJ murations, triplet repeats,"3 and in a growing number of dominant and recessive X Jinked gene disorders, such as Duchenne muscular dystrophyy4 hae-mophilia B/' Conradi-Hunermann-Happle syndrome,:e and double corte.N/Iissencephaly syndrome.*" Because a proporrion of cells carry the mutation not only in blood but also in tis-sues dermng from other celi lineages. it musi be assumed that the mutation occurred very eariy during embryogenesis.
Finally, the derection of mosaic mutation depends mainly on the method used for the identihcation of mutations within the MECP2 gene. Nowadays. the method of choice for identifying deleterious murations relies on direer DNA seąuencing. The ability of this method to derect mosaic mutations is poor, which is parricularly truć when the mosaicism rare is Iow. Our findings underline the need for ar least two complemenrary approaches, such as methods based on heterodup!ex analysis and seąuencing, for an efhcient screening of the MECP2 gene.
Vfc thank Dr Dcblay tor criucal advice, Dr rlnrencc Rousselci for her techntcał contnbution, and rAssoctation Franęaisc du Syndrome dc Ren, l’Assoriatton Franęaisc contrę Ics myopa-tbirs, and the Minisierc dc rEducation Nationale, dc la Re che r-che et dc Ja Technologie for their łinunciai support.
J Rett A. On an unusual hrain atrophv syndrome in hyperam-moncmia in Childhood. WiatMai U7>;itauchr 1966;!1:723-6.
2 Ilagbcrg B, Aicardi J, Dijs K, Ramus O. A progrcssivc syndrome oj uutism, demem ia, aiaxia, and ioss of purposcfuJ band usc in girls: Rctt\ syndrome. report of 33 cases.
AvW J 9*3,14:47]-9.
3 Amir RE, V;in den Vcyvcr JU.W.tn M.Tran CQ, Frunckc U,
Zoghbi HY. Rett syndrome is causa; by mutations in X-linkcd MUC.”-, cncoding mcfhvJ-Cp(Vbinding protein 2. Kai Gausi 23:!X5-b.
4 Nan X, Cumpoy FJ, Bi ni A. McCP2 is a transcriptional
irpreSsor with ahundant hinding stres in genomie chrom a-tin.GV/lP07 ,21:471-81.
5 Amir RE, Yan den Veyvcr IB, Schulfz R, Malicki J3M, Tran
CQ, Dahlc F.J, Philippi A, Timar U Percy AK. Moiił KJ, Lichtargc O, Smith EO, Glazc DO, Zoghbi HY. Influenco of rnuuuion type and X chromosumc inactfcition on Ren syndrome phcrjOtypeS. Ann N<tuml 2000;47:670-9.
0 Amano K, Nomura Y, Segawa M, Yamakaw a K. Mututlonal analysis of the MECP2 gene in Japanesc patiem* with Ren syndrome. J Hmn Gam 2000;45:213-36
7 Bienwnu T, Carrie A, de Roux N, Vinci MC, Jonveaux R, Com-crt P, Villard L, Ar/imanoglou A. Bełdjord C, Fontcs M, Tardieu M, Chelly J. MEĆP2 muiatiuns account for most cases of typical forms of Ren syndrome. Hum Mol Gam 2000,9:1377-84.
8 Buyse JM, Fang P, Hoon KT, Amir RE. Zoghbi HY, Roa
BB. Dtagnostic testing for Rett syndrome by DHPLC and dircci sequcncc analysis of the MECP2 gene: tdenufication of se\erjl nowel mutations and pnlvmorphi$ms. Am J IIuw Gam 2000;67:M2S-36.
9 Chcadle ]Jy, Gili H, Fleming N. Maynard J, Kcrr A, Leonjrd
H, Kxaivc2dk M. Cooper DN, Lynch S, Iliom as N. Hughes H, Hullcn M, Ranne D, Sjmpson JR, Ciarkę A. Long-read sequcnce analysis of the MECP2 gene tr. Ren syndrome patients: correlation of discasc sewrity uiih muiaóon type and location. Hm u Mo/ Gani 2000;9:1119-29.
10 De Bona C.ZappeJla M.Huyek G, Meloni I, Yiicili F, Bruj-
tim M, Cus;ino R, Loflredo P, Lo.ngo I, Renieri A. Presened speech variant is allelic of classic Ren stndrome. EurJHutu Gam 2000;S:325-30.
11 Harnpson K, Woods CG,Laiif F, \Y-ebb T Mutations in she
MECP2 gene in a cohort of girls wiih Rc:t senJrome. 7 M<d Gam 2000;37:010-12.
12 Huppke P, LacconcT, Kramer N’, Engel V. HancfelJ F. Rett syndrome: analysis of MECP2 and clinical cha^icten/jjion of 31 patients. Huni Mol Gam 2000;9:1300-73.
13 Oba ta K, Matsuishi T, Yamashita Y, Fukuda T, KuwaHma
K, Horiuchi I, Kagamitsu S, Iwanaga R, Kimura A, Omon J, Endo S, Mori K, Kondo I. Mutation analysis of the methvl-CpG btnding protein 2 gene (MEC1*2) in patients with kert syndrome. JMcd Gam 2000;37:60S-10.
14 W art M, l^c SS, Zhanę X, Houwink MI, Song HR. Amir
RE, Buddęn S, N:aidu S, Pereira Jl^ Lo IF, Żoghbi HY, Schancn NC, Franckc U. Rett syndrome and bcyond: recurrcnt spontaneous and familia! MECP2 mutations at CpG hotspots. Am J Huni Gam lr<°9;65:l 520-°
15 Xiang F, Buervemch S, Kicoiao P, Bailey ME, Zhang Z, Anvret M. Mutation screening in Rett syndrome patients. j \Ud Gam 2000;37:250-5.
16 Bourdon V, Phiiippe C, Labrunc O, Amsallem D, Amould
C> Jonvcaux P. A detailed analysis of the MECP2 cenc: prc\-alcncc of recurrcnt mutations jru gross DNA rearrangemems in Rett syndrome patients Huni Gam 2001;108:43-50.
17 Reichwald K, Thiescn j, Wiehc T', Wcitzcl J, Statiir.g W H, Kioschis P, Poustka A, Roscnuhal A, Platzer M. Compara-ri%-c seąuencc analysis of the MECP2-locus in human and mousc revcais new transcribed regions. Mamut Genome 2000J11:182-90.
IS Trev3rthcn E, Moscr H\V, and the Diagnostic Criteria Wotking Group. Diagnoście criteria lor Rett syndrome. The Rett Syndrome Diagnostic Criteria Work Group. Ann Seumi 19SŚ;23.425-8.
I(* Phiiippe C, Porter DE, Emcrton ME, Wells DE, Stmpson AHRW, Monaco .•Vl>. Mutation screening of *hc ENT.’ and EX7'2 gen es in patients'with hereditary multiplc esostoses Am J Hun/ Gam 1997;61:520-8.
20 Walsh PS, Metzger DA, Higuchi R. Chclcs 100 as a medium
for simplc estraction of DNA for PCR-based typing from forensic matertal. BiouJmięues 1991;10:506-13.
21 Chandler SP, Guschin D, Landsbcrgcr Wolfie AP Ihe methyl-CpG bmding transcripticna! repressor McC?2 sta-blv associaies with nuclcosomai DNA Bioc/ianiun- 199°; 58:7008-1$.
22 Cfaytoo-Smith J, Watson P, Ramsdcn S, Black GCM.
Somatic mutation in MECP2 as a non-fatal neurodcvclop-mental disorder in males. lunicet 2000;356:830-2.
23 Bcrnards A, Gusclla JF. The importancc of genciic
mosaicism in human discasc. K llnęt ^ Med -994;53l: 1447-9.
24 Bunyan DJ, Robinson DO, Collins AL, CocfcwcR AE, Buli-
man HMS, Whinaker PA. Gcrmlinc ar.d somatic mosaicism in u femak carrier of Duchenne muscular dystrophy Huni Gam 1994;93:541-4.
25 Costa J-M, Vidaud D, I-iurcndreau I, Vidaud M, Fressin-
aud E, Moisa.n JP, Davrd A. Meyer D, Lave.*gnc JM. Somatic mosaicism and compound heitrozygosity in femalc hemophilia B. 5/l>oJ2(KX);96:J585-7.
20 Has C, Bruckner-Tudcrman L, Muller D, floeih M, Folkcrs E, Donnai D, Traupe H. The Conradi-Hunermann-Happle syndrome (CDI*X2) and emopamil binding protein: novcl mutations, and somatic and gonada! mosaicism. Huni Moi Genui 2000;9:1 <>5l-5.
27 Gleeson Ki. Minncrath H, Kuzniccky RI. l)obvns W B, Young 113, Ross Mli, Walsh CA. Somatic und gcrmlinc mosaic mulations in the doubiccortin genc are assoaated with '.si.n-ablc phcnolypes Am 711 tan Gam 2000;67:574-8 J
BMT
Pubiishfng
Group
BMA House, Tavistock Sąuare, London WC2 H 9JR. Tel. 020 7383 6305. Fax 020 7383 6699 ^ 2001. AU righrjs of rcproduction of this reprint arc re^eryed in alj couniries of the world.
Printed in Greai Briiain by Meridian Print Centrę Ltd. Derby. JMG/Dec^l